Commentary to: Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM)Hannah Carter, Josue Samayoa, Ralph H.
No takes yet. Share an insight, caveat, or question.
Murray Korc (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: